Literature DB >> 10976611

Changes in injection risk behavior associated with participation in the Seattle needle-exchange program.

H Hagan1, H Thiede.   

Abstract

We studied the influence of the Seattle, Washington, needle-exchange program on sharing of drug injection equipment (syringes, drug cookers, filtration cotton) to identify potential gaps in risk reduction and to understand in greater detail the lack of an association between exchange use and risk of hepatitis B or C virus transmission. In a cohort of 2,208 injection drug users who completed a 1-year follow-up visit, we measured the association between needle-exchange use at study enrollment (ever vs. never) and injection risk behavior at the follow-up. Control for confounding was carried out using both logistic regression and propensity score analytic methods to estimate the adjusted odds ratio (AOR). In both univariate and multivariate analyses, needle-exchange use was associated with a lower likelihood of injection with a used syringe (AOR = 0.7, 95% confidence limit 0.5, 0.9). There was no association between exchange use and cooker or cotton sharing (AOR = 0.8, 95% confidence limit 0.6, 1.1) or between exchange use and use of a common syringe to divide drugs (AOR = 0.9). This analysis suggests that risk reduction measures adopted by users of the Seattle exchange may not be sufficient to prevent transmission of all blood-borne viruses, including hepatitis C virus. Greater awareness of the infection risk associated with these practices may help curb this type of equipment sharing and ultimately prevent disease transmission.

Entities:  

Mesh:

Year:  2000        PMID: 10976611      PMCID: PMC3456035          DOI: 10.1007/BF02386747

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  26 in total

1.  Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.

Authors:  R B D'Agostino
Journal:  Stat Med       Date:  1998-10-15       Impact factor: 2.373

2.  New needle and syringe use, and use of needle exchange programmes by street recruited injection drug users in 1993.

Authors:  R J MacGowan; C E Sterk; A Long; R Cheney; M Seeman; J E Anderson
Journal:  Int J Epidemiol       Date:  1998-04       Impact factor: 7.196

3.  The effectiveness of adjustment by subclassification in removing bias in observational studies.

Authors:  W G Cochran
Journal:  Biometrics       Date:  1968-06       Impact factor: 2.571

4.  Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program.

Authors:  H Hagan; D C Jarlais; S R Friedman; D Purchase; M J Alter
Journal:  Am J Public Health       Date:  1995-11       Impact factor: 9.308

5.  Incidence of bloodborne virus infection and risk behaviours in a cohort of injecting drug users in Victoria, 1990-1995.

Authors:  N Crofts; C K Aitken
Journal:  Med J Aust       Date:  1997-07-07       Impact factor: 7.738

6.  Sharing of drug preparation equipment as a risk factor for hepatitis C.

Authors:  H Hagan; H Thiede; N S Weiss; S G Hopkins; J S Duchin; E R Alexander
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

7.  Needle exchange use among a cohort of injecting drug users.

Authors:  E E Schoenbaum; D M Hartel; M N Gourevitch
Journal:  AIDS       Date:  1996-12       Impact factor: 4.177

8.  High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study.

Authors:  J Bruneau; F Lamothe; E Franco; N Lachance; M Désy; J Soto; J Vincelette
Journal:  Am J Epidemiol       Date:  1997-12-15       Impact factor: 4.897

Review 9.  HIV prevention among injecting drug users: responses in developing and transitional countries.

Authors:  A L Ball; S Rana; K L Dehne
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

10.  Syringe and needle exchange as HIV/AIDS prevention for injection drug users.

Authors:  J K Watters; M J Estilo; G L Clark; J Lorvick
Journal:  JAMA       Date:  1994-01-12       Impact factor: 56.272

View more
  18 in total

1.  Case-reporting of acute hepatitis B and C among injection drug users.

Authors:  Holly Hagan; Nadine Snyder; Eileen Hough; Tianji Yu; Shelly McKeirnan; Janice Boase; Jeffrey Duchin
Journal:  J Urban Health       Date:  2002-12       Impact factor: 3.671

2.  Hepatitis C screening and management practices: a survey of drug treatment and syringe exchange programs in New York City.

Authors:  Chi-Chi N Udeagu Pratt; Denise Paone; Rosalind J Carter; Marcelle C Layton
Journal:  Am J Public Health       Date:  2002-08       Impact factor: 9.308

Review 3.  The provision of non-needle/syringe drug injecting paraphernalia in the primary prevention of HCV among IDU: a systematic review.

Authors:  Michelle Gillies; Norah Palmateer; Sharon Hutchinson; Syed Ahmed; Avril Taylor; David Goldberg
Journal:  BMC Public Health       Date:  2010-11-23       Impact factor: 3.295

4.  Increased access to unrestricted pharmacy sales of syringes in Seattle-King County, Washington: structural and individual-level changes, 1996 versus 2003.

Authors:  Ryan J Deibert; Gary Goldbaum; Theodore R Parker; Holly Hagan; Robert Marks; Michael Hanrahan; Hanne Thiede
Journal:  Am J Public Health       Date:  2006-06-29       Impact factor: 9.308

Review 5.  A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods.

Authors:  Til Stürmer; Manisha Joshi; Robert J Glynn; Jerry Avorn; Kenneth J Rothman; Sebastian Schneeweiss
Journal:  J Clin Epidemiol       Date:  2005-10-13       Impact factor: 6.437

6.  Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City.

Authors:  Crystal M Fuller; Sandro Galea; Wendy Caceres; Shannon Blaney; Sarah Sisco; David Vlahov
Journal:  Am J Public Health       Date:  2006-11-30       Impact factor: 9.308

7.  Hospital- versus community-based syringe exchange: a randomized controlled trial.

Authors:  Carmen L Masson; James L Sorensen; David C Perlman; Michael S Shopshire; Kevin L Delucchi; TeChieh Chen; Karl Sporer; Don Des Jarlais; Sharon M Hall
Journal:  AIDS Educ Prev       Date:  2007-04

Review 8.  In the clinic. Hepatitis C.

Authors:  Janice H Jou; Andrew J Muir
Journal:  Ann Intern Med       Date:  2008-06-03       Impact factor: 25.391

9.  Risk factors for hepatitis B in an outbreak of hepatitis B and D among injection drug users.

Authors:  Stephanie R Bialek; William A Bower; Karen Mottram; Dave Purchase; T Nakano; Omana Nainan; Ian T Williams; Beth P Bell
Journal:  J Urban Health       Date:  2005-07-27       Impact factor: 3.671

10.  Sexual relationships, secondary syringe exchange, and gender differences in HIV risk among drug injectors.

Authors:  Kara S Riehman; Alex H Kral; Rachel Anderson; Neil Flynn; Ricky N Bluthenthal
Journal:  J Urban Health       Date:  2004-06       Impact factor: 3.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.